Zelluna ASA (OSL:ZLNA)

Norway flag Norway · Delayed Price · Currency is NOK
13.60
-0.40 (-2.84%)
At close: May 12, 2025
-37.33%
Market Cap 275.09M
Revenue (ttm) 53.00K
Net Income (ttm) -105.16M
Shares Out 20.23M
EPS (ttm) -85.99
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 7,182
Average Volume 16,587
Open 13.24
Previous Close 14.00
Day's Range 13.24 - 14.55
52-Week Range 1.57 - 124.60
Beta n/a
RSI 40.19
Earnings Date May 8, 2025

About Zelluna ASA

Zelluna ASA develops T-cell receptor (TCR) cellular immunotherapy products for the treatment of solid cancers. The company was founded in 2016 and is based in Oslo, Norway. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2016
Employees 22
Stock Exchange Oslo Børs
Ticker Symbol ZLNA
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.